Compare Repligen Corporation Common Stock (RGEN) vs Vanguard Information Technology Index Fund ETF (VGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Repligen Corporation Common Stock vs Vanguard Information Technology Index Fund ETF — how do they compare? Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B), while Vanguard Information Technology Index Fund ETF trades at $121.67 (market cap $170.20B). The key difference: Vanguard Information Technology Index Fund ETF is far larger — about 15× Repligen Corporation Common Stock's market cap, and Vanguard Information Technology Index Fund ETF is more actively traded (6,852,336 versus 1,216,919). Which is the better fit depends on your goals — on Pluang, investors hold Repligen Corporation Common Stock for 0 Days and Vanguard Information Technology Index Fund ETF for 130 Days on average.
| RGEN | VGT | |
|---|---|---|
Market Cap | $11.31B | $170.20B |
Volume | 1,216,919 | 6,852,336 |
Sector | Health | — |
52-Week High | $194.57 | $129.79 |
52-Week Low | $102.87 | $83.59 |
Typical Hold Time | 0 Days | 130 Days |
Enterprise Value | $11.20B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
VGT trades at $126.48, down slightly by 0.02% today, but maintains a bullish technical stance with strong moving average signals. The ETF, focused on U.S. technology stocks, has delivered robust historical returns, with recent news highlighting its low expense ratio and concentration in top tech giants like Nvidia, Apple, and Microsoft. A dividend of $0.15 is scheduled for late September 2026.
The outlook for VGT remains positive given technology sector growth and AI-driven momentum, though risks include sector concentration and valuation sensitivity. Investor sentiment is buoyed by strong past performance and institutional inflows, but macroeconomic shifts could pose headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →About Vanguard Information Technology Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index/Information Technology 25/50, an index made up of stocks of large, mid-size, and small US companies within the information technology sector, as classified under the GICS. The advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VGT →
